Skip to main content
. 2023 Oct 12;8(6):1547–1556. doi: 10.1002/lio2.1166

FIGURE 1.

FIGURE 1

Matrix metalloproteinase‐1 (MMP‐1) levels in saliva from 792 clinical specimens. (A) Salivary levels of MMP‐1 in oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC) patients were determined using an enzyme‐linked immunosorbent assay kit. The OSCC patients had significantly higher saliva MMP‐1 levels than the OPMD patients. (B) Receiver operating characteristic (ROC) curve showing the diagnostic efficacy of salivary MMP‐1 for discriminating OSCC and OPMD patients. The area under the ROC curve (AUC) was 0.8869, p < .0001.